Evidence map›Paper›PMID 31270820›Full record

ArticleThe Journal of physiology2019

Urocortin 3 signalling in the auditory brainstem aids recovery of hearing after reversible noise-induced threshold shift.

Matthew J Fischl, Margarete A Ueberfuhr, Markus Drexl, Sara Pagella, James L Sinclair, Olga Alexandrova, Jan M Deussing, Conny Kopp-Scheinpflug

Open access · hybridAbstract read
In one paragraph

Article in The Journal of physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Matthew J FischlDepartment of Biology II, Division Neurobiology, Ludwig-Maximilians-University, Munich, Germany.
Margarete A UeberfuhrGerman Center for Vertigo and Balance Disorders, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany.
Markus DrexlGerman Center for Vertigo and Balance Disorders, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany.
Sara PagellaDepartment of Biology II, Division Neurobiology, Ludwig-Maximilians-University, Munich, Germany.
James L SinclairDepartment of Biology II, Division Neurobiology, Ludwig-Maximilians-University, Munich, Germany.
Olga AlexandrovaDepartment of Biology II, Division Neurobiology, Ludwig-Maximilians-University, Munich, Germany.
Jan M DeussingMax Planck Institute of Psychiatry, Molecular Neurogenetics, Munich, Germany.
Conny Kopp-ScheinpflugDepartment of Biology II, Division Neurobiology, Ludwig-Maximilians-University, Munich, Germany.ORCID 0000-0002-8083-6232
Ludwig-Maximilians-Universität München · DEGerman Center for Lung Research · DEMax Planck Institute of Psychiatry · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

key pointsOngoing, moderate noise exposure does not instantly damage the auditory system but may cause lasting deficits, such as elevated thresholds and accelerated ageing of the auditory system. The neuromodulatory peptide urocortin-3 (UCN3) is involved in the body's recovery from a stress response, and is also expressed in the cochlea and the auditory brainstem. Lack of UCN3 facilitates age-induced hearing loss and causes permanently elevated auditory thresholds following a single 2 h noise exposure at moderate intensities. Outer hair cell function in mice lacking UCN3 is unaffected, so that the observed auditory deficits are most likely due to inner hair cell function or central mechanisms. Highly specific, rather than ubiquitous, expression of UCN3 in the brain renders it a promising candidate for designing drugs to ameliorate stress-related auditory deficits, including recovery from acoustic trauma. ABSTRACT: Environmental acoustic noise is omnipresent in our modern society, with sound levels that are considered non-damaging still causing long-lasting or permanent changes in the auditory system. The small neuromodulatory peptide urocortin-3 (UCN3) is the endogenous ligand for corticotropin-releasing factor receptor type 2 and together they are known to play an important role in stress recovery. UCN3 expression has been observed in the auditory brainstem, but its role remains unclear. Here we describe the detailed distribution of UCN3 expression in the murine auditory brainstem and provide evidence that UCN3 is expressed in the synaptic region of inner hair cells in the cochlea. We also show that mice with deficient UCN3 signalling experience premature ageing of the auditory system starting at an age of 4.7 months with significantly elevated thresholds of auditory brainstem responses (ABRs) compared to age-matched wild-type mice. Following a single, 2 h exposure to moderate (84 or 94 dB SPL) noise, UCN3-deficient mice exhibited significantly larger shifts in ABR thresholds combined with maladaptive recovery. In wild-type mice, the same noise exposure did not cause lasting changes to auditory thresholds. The presence of UCN3-expressing neurons throughout the auditory brainstem and the predisposition to hearing loss caused by preventing its normal expression suggests UCN3 as an important neuromodulatory peptide in the auditory system's response to loud sounds.

Indexed as

AgingAnimalsAuditory ThresholdEvoked Potentials, Auditory, Brain StemFemaleHair Cells, Auditory, OuterHearing Loss, Noise-InducedMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicNoiseSignal TransductionUrocortinsurocortin 3 protein, mouseUrocortinsacoustic traumaageingauditory brainstem responsesCorticotropin-releasing hormone receptorDPOAEsneuropeptidestress recoveryurocortin

Identifiers

PMID31270820
PMCPMC6852351
OpenAlexW2953840061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.